Cinta Diez-Ardanuy is a Senior Investment Associate at Invivo Partners, a venture capital firm focused on drug development, advanced therapies, and biomedical innovation. She holds degrees in Biochemistry (UAB) and Biotechnology (URV), a PhD in Biomedical Sciences from the University of Strathclyde (UK), and a Master’s in Global Health and Cooperation (UAB). Before joining Invivo, she worked in technology transfer at Pompeu Fabra University and has served as an expert evaluator for European healthcare innovation programmes, including Horizon Europe and EIT Health. At Invivo, she focuses on identifying and supporting innovative drug development opportunities across the European life sciences ecosystem.